Chimeric Antigen Receptor (CAR)-Modified T Cells (CTL019) Induce Durable CNS Remissions in Children with CNS/Combined Bone Marrow and CNS Relapsed/Refractory CD19+Acute Lymphoblastic Leukemia

PEDIATRIC BLOOD & CANCER(2017)

引用 0|浏览4
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要